Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer
Clinical trial NCT02632045 · COMPLETED
Trial details
- NCT number
- NCT02632045
- Sponsor
- Melissa K Accordino
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2022-01-04
- Enrollment
- 169
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.